Document is current
Any future updates will be listed below
-
Authors
Park, Sujin
Yoon, Kwiyeom
Hong, Eunji
Kim, Min Woo
Kang, Min Gi
Mizuno, Seiya https://orcid.org/0000-0002-6740-5817
Kim, Hye Jin
Lee, Min-Jung
Choi, Hee Jae
Heo, Jin Sun
Bae, Jin Beom
An, Haein
Park, Naim
Park, Hyeyeon
Kim, Pyunggang
Son, Minjung
Pang, Kyoungwha
Park, Je Yeun
Takahashi, Satoru https://orcid.org/0000-0002-8540-7760
Kwon, Yong Jung
Kang, Dong-Woo
Kim, Seong-Jin
-
Funding
Funding for this research was provided by:
Korea Drug Development Fund (RS-2023-00282595)
Korea Drug Development Fund (RS-2023-00282595)
Korea Drug Development Fund (RS-2023-00282595)
Korea Drug Development Fund (RS-2023-00282595)
Korea Drug Development Fund (RS-2023-00282595)
Korea Drug Development Fund (RS-2023-00282595)
Korea Drug Development Fund (RS-2023-00282595)
Korea Drug Development Fund (RS-2023-00282595)
Korea Drug Development Fund (RS-2023-00282595)
Korea Drug Development Fund (eptube@medpacto.com)
Korea Drug Development Fund (RS-2023-00282595)
Korea Drug Development Fund (RS-2023-00282595)
Korea Drug Development Fund (RS-2023-00282595)
Korea Drug Development Fund (RS-2023-00282595)
Korea Drug Development Fund (RS-2023-00282595)
- License Information
-
More Information
Article History
Received: 28 August 2024
Revised: 2 January 2025
Accepted: 20 February 2025
First Online: 24 March 2025
Competing interests
: S.J.K. is the founder of Medpacto and serves on its Board of Directors. K.Y., M.W.K., H.J.K., M.J.L., J. B. B., N. P., D.W.K., and S.J.K. are employees of Medpacto. The GILO Foundation has received research support from Medpacto. The other authors declare no competing interests.
